ipamorelin/cjc-1295 pittsburgh CJC-1295 No DAC & Ipamorelin cjc-1295 ipamorelin clinical trial growth – CJC-1295 + Ipamorelin — Research

Ipamorelin is a GHRP (ghrelin receptor agonist) that amplifies GH pulse amplitude

Czechia 99.7 % purity confirmed by COA Assay content verified at 12.24 mg Identification confirmed by FTIR and retention time analysis Molecular ion mass identified at 848 Da Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination DSIP peptide research compound For research use only not for human or veterinary use For laboratory research only

Research areas include matrix protein interaction studies, cellular migration pathway analysis, and peptide behavior characterization

After 1 year of treatment, the patients biological age was reduced by 7.9 years (from 75.93 to 68.03), and his telomere length increased from 6.45 to 6.59 kb (Table 3)